[et_pb_section][et_pb_row][et_pb_column type=”4_4″][et_pb_text admin_label=”Text” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
The frequent misconception that bariatric surgery is associated with markedly elevated rates of complications and mortality is not supported by the available data. A meta-analysis of 361 studies that included a total of 85,048 patients showed an overall mortality of 0.28% within 30 days after surgery, and a mortality of 0.35% between 30 days and 2 years after surgery.31 Several other studies reported surgical mortality of 0.25%–0.50%.32–35 The Longitudinal Assessment of Bariatric Surgery consortium conducted a multicenter, prospective observationalstudy of 30-day outcomes in patients who underwentbariatric surgery at 10 clinical sites in the US between 2005 and 2007.36 The30-day death rate among patients who underwent RYGB or LAGB was0.3%, and in total 4.1% of patients experienced at least one major adverseevent.36 Of note, mortality rates associated with bariatric surgery are equivalent with those of several common abdominal surgeries, such as laparoscopic cholecystectomy, which has a mortality rate of 0.3–0.6% in the US.37 Another study, which analyzed the data of more than 9,500 patients who underwent bariatric surgery at 652 hospitals in the US, showed an impressive 21% decline in 6-month, risk-adjusted complication rates.38 The study also found that inpatient complication rates fell from 24% to 15%, despite inclusion of a high percentage of elderly and ailing operative patients. These data demonstrate that over the past several years, morbidity and mortality associated with bariatric surgery have steadily declined. Such improvements have been largely attributed to the widespread use of minimally invasive laparoscopic techniques, in addition to other factors,39,40 such as implementation of centers of excellence and greater experience with the procedures.